231 related articles for article (PubMed ID: 16139567)
1. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
Heeringa P; Huugen D; Tervaert JW
Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of ANCA-associated vasculitides.
Kallenberg CG
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
[TBL] [Abstract][Full Text] [Related]
3. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
van der Veen BS; Heeringa P
APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW
Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
6. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
7. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
Csernok E; Gross WL
Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Tervaert JW; Heeringa P
Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
[TBL] [Abstract][Full Text] [Related]
9. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
12. Epitope-specific anti-neutrophil cytoplasmic antibodies: do they matter? Can they be detected?
Specks U
APMIS Suppl; 2009 Jun; (127):63-6. PubMed ID: 19515143
[TBL] [Abstract][Full Text] [Related]
13. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.
Savage CO; Gaskin G; Pusey CD; Pearson JD
Exp Nephrol; 1993; 1(3):190-5. PubMed ID: 7915959
[TBL] [Abstract][Full Text] [Related]
15. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
17. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.
Savage CO; Pottinger BE; Gaskin G; Pusey CD; Pearson JD
Am J Pathol; 1992 Aug; 141(2):335-42. PubMed ID: 1323218
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]